Abstract
The fibrinolytic system is the physiological counterpart of the coagulation system. Formed from fibrinogen by thrombin after activation of the coagulation cascade, fibrin is not meant to be a permanent structure in the body, but a temporary one bound to be removed by proteolytic enzymes. The most important of these enzymes is plasmin that, by limited proteolytic cleavage, degrades the insoluble polymer fibrin into soluble fragments, the fibrin degradation products. As plasmin is a broad spectrum protease and can degrade many plasma proteins, it will not normally be present in the blood in its active form, but as an inactive pro-enzyme (plasminogen). Plasminogen is activated into plasmin by other specific proteases: the plasminogen activators. Of the three types of plasminogen activators present in the blood, tissue-type plasminogen activator (t-PA) is considered to be the most important for intravascular fibrinolysis. The role of the other two plasma plasminogen activators in intravascular fibrinolysis (plasma pro-urokinase, and the Factor Xll-dependent plasminogen pro-activator, both circulating in blood as pro-enzymes) is still obscure. Not only is fibrin the substrate for plasmin, but it also dramatically accelerates plasminogen activation by t-PA, thus virtually limiting plasmin formation to the surface of its substrate fibrin. Moreover, fibrin protects plasmin from inactivation by protease inhibitor α2-antiplasmin, which rapidly inactivates plasmin in the fluid phase. Plasminogen activator activity is regulated by other specific protease inhibitors, the plasminogen activator inhibitors (PA inhibitors). The fibrinolytic system is schematically depicted in Fig. 1. For more detailed descriptions of the fibrinolytic system, the reader is referred to recent reviews (1–5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aoki N. Sem. Thromb. Haemostas. 10: 1 (1984).
Collen D., Lijnen H.R. and Verstraete M. Thrombolysis, Churchill Livingstone, Edinburgh (1985).
Emeis J.J., Brommer E.J.P., Kluft C. and Brakman P. In: Recent Advances in Blood Coagulation (Poller, L. ed), Churchill Livingstone, Edinburgh. 4: 11 (1985).
Kluft C. Tissue-type Plasminogen Activator (t-PA), Physiological and Clinical Aspects, CRC Press, Boca Raton (in press).
Verstraete M. and Collen D. Blood 67: 1529 (1986).
Erickson L.A., Schleef R.R., Ny T. and Loskutoff D.J. Clin. Haematol. 14: 513 (1985).
Van Hinsbergh V.W.M. In: Tissue-type Plasminogen Activator (t-PA) Physiological and Clinical Aspects (Kluft C., ed) CRC Press, Boca Raton (in press).
Todd A.S. Bibl. Anat. 12: 18 (1973).
Rijken D.C., Wijngaards G. and Welbergen J. Thromb. Res. 18: 815 (1980).
Kristensen P., Larsson L.-I., Nielsen L.S., Grondahl-Hansen J., Andreasen P.A. and Dano K. FEBS Lett. 168: 33 (1984).
Emeis J.J. In: Tissue-type Plasminogen Activator (t-PA), Physiological and Clinical Aspects (Kluft C., ed) CRC Press, Boca Raton (in press).
Larsson L.-I., Skriver L., Nielsen L.S., Grondahl-Hansen J., Kristensen P. and Dano K. J. Cell Biol. 98: 894 (1984).
Dano K., Andreasen P.A., Grondahl-Hansen J., Kristensen P., Nielsen L.S. and Skriver L. Adv. Cancer Res. 44: 139 (1985).
Kadouri A. and Bohak Z. Adv. Biotechn. Proc. 5: 275 (1985).
Waller E.K. and Schleuning W.-D. Biol. Chem. 260: 6354 (1985).
Crutchley D.J. and Smariga P.E. Biochim. Biophys. Acta 886: 26 (1986).
Crutchley D.J., Conanan L.B. and Maynard J.R. Cancer Res. 40: 849 (1980).
Crutchley D.J. and Maynard J.R. Biochim. Biophys Acta. 762: 76 (1983).
Crutchley D.J., Conanan L.B. and Maynard J.R. J. Pharmacol. Exp. Ther. 222: 544 (1982).
Laug W.E., Jones P.A., Nye C.A. and Benedict W.F. Biochem. Biophys. Res. Commun. 68: 114 (1976).
Soreq H., Miskin R., Zutra A. and Littauer U.Z. Dev. Brain Res. 7: 257 (1983).
Rifkin D.B. J. Cell. Physiol. 97: 421 (1978).
Hamilton J.A., Lingelbach S.R., Partridge N.C. and Martin T.J. Biochem. Biophys. Res. Commun. 122: 230 (1984).
Canipari R. and Strickland S. J. Biol. Chem. 260: 5121 (1985).
Strickland S. and Beers W.H. J. Biol. Chem. 251: 5694 (1976).
Vassalli J.-D., Dayer J.-M., Wohlwend A. and Belin D. J. Exp. Med. 159: 1653 (1984).
Vassalli J.-D., Hamilton J.A. and Reich E. Cell 8: 271 (1976).
Hamilton J.A. J. Reticuloend. Soc. 30: 115 (1981).
Hamilton J.A., Leizer T. and Lingelbach S.R. Biochim. Biophys. Acta 886: 195 (1986).
Hamilton J.A. J. Rheumatol. 10: 872 (1983).
Drapier J.-C. and Petit J.-F. Int. J. Immunopharmacol. 6: 345 (1984).
Bounameaux H., Verstraete M. and Collen D. In: Thrombolysis (Collen D., Lijnen H.R. and Verstraete M. eds), Churchill Livingstone, Edinburgh, p. 85 (1985).
Prowse C.V. and Cash J.D. Sem. Thromb. Haemostas. 10: 51 (1984).
Prowse C.V. and MacGregor I.R. In: Tissue-type Plasminogen Activator (t-PA) Physiological and Clinical Aspects (Kluft C., ed) CRC Press, Boca Raton (in press).
Emeis J.J. and Kluft C. Blood 66: 86 (1985).
Klöcking H.-P., Markwardt F. and Hoffmann A. Thromb. Res. 38: 413 (1985).
Emeis J.J. Thromb. Res. 30: 195 (1983).
Jansen J.W.C.M. and Olieberg H.H. Fibrinolysis 1, suppl. 1: 72 (1986).
Emeis J.J. Unpublished observations (1986).
Singer H.A., Saye J.A. and Peach M.J. Blood Vessels 21: 223 (1984).
Bertele V. and Salzman E.W. Arteriosclerosis 5: 119 (1985).
Dembinska-Kiec A., Kostka-Trabka E., Zmuda A. et al. Pharmacol. Res. Commun. 14: 485 (1982).
Korbut R., Byrska-Danek A. and Gryglewski R.J. Thromb. Haemostas. 50: 893 (1983).
Musial J., Wilczynska M., Sladek K. et al. Prostaglandins 31: 61 (1986).
Szczeklik A., Kopec M., Sladek K. et al. Thromb. Res. 29: 655 (1983).
Menon I.S. Lancet i: 364 (1970).
Moroz L.A. New Engl. J. Med. 296: 525 (1977).
Levin R.I., Harpel P.C., Weil D., Chang T.-S. and Rifkin D.B. J. Clin. Invest. 74: 571 (1984).
Bounameaux H., Gresele P., Hanss M., De Cock F., Vermylen J. and Collen D. Thromb. Res. 40: 161 (1985).
Keber I. and Keber D. Thromb. Res. 39: 761 (1985).
Hammouda M.W. and Moroz L.A. Thromb. Res. 42: 73 (1986).
Korninger C., Kircheimer J., Christ G., Schwaiger N. and Binder B.R. Thromb. Haemostas. 54: 175 (1985).
Mussoni L., Carriero M.R., Cerletti C. and De Gaetano G. Blood 66: 352a (1985).
Mussoni L., Carriero M.R., Cerletti C. and De Gaetano G. Fibrinolysis 1, Suppl. 1: 171 (1986).
Keber I., Jereb M. and Keber D. Fibrinolysis 1, Suppl. 1: 175 (1986).
Brommer E.J.P., Derkx, F.H.M., Barrett-Bergshoeff M.M. and Schalekamp M.A.D.H. Thromb. Haemostas. 51: 42 (1984).
Innes D. and Sevitt S. J. Clin. Pathol. 17: 1 (1964).
Risberg B. Eur. Surg. Res. 10: 373 (1978).
Risberg B. J. Surg. Res. 26: 698 (1979).
Saldeen T. The microembolism syndrome, Almguist and Wiksell, Stockholm (1979).
Aillaud M.F., Juhan-Vague I., Alessi M.C. et al. Thromb. Haemostas. 54: 466 (1985).
D’Angelo A., Kluft C., Verheijen J.H. et al. Eur. J. Clin. Invest. 15: 308 (1985).
Kluft C., Verheijen J.H., Jie A.F.H. et al. Scand. J. Clin. Lab. Invest. 45: 605 (1985).
Mellbring G., Dahlgren S. and Wiman B. Acta Chir. Scand. 151: 109 (1985).
Emeis J.J. and Kooistra T. J. Exp. Med. 163: 1260 (1986).
Bevilacqua M.P., Schleef R.R., Gimbrone M.A. and Loskutoff D.J. J. Clin. Invest. 78: 587 (1986).
Nachman R.L., Hajjar K.A., Silverstein R.L. and Dinarello C.A. J. Exp. Med. 163: 1595 (1986).
Colucci M., Paramo J.A. and Collen D. J. Clin. Invest. 75: 818 (1985).
Dubor F., Dosne A.M. and Chedid L.A. Inf. Imm. 52: 725 (1986).
Crutchley D.J. and Conanan L.B. J. Biol. Chem. 261: 154 (1986).
Engebretsen L.F., Kierulf P. and Brandtzaeg P. Thromb. Res. 42: 713 (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this paper
Cite this paper
Emeis, J.J. (1987). The Role of Lipid Mediators in Blood Fibrinolysis. In: Paubert-Braquet, M., Braquet, P., Demling, B., Fletcher, J.R., Foegh, M. (eds) Lipid Mediators in the Immunology of Shock. NATO ASI Series, vol 139. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0919-2_26
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0919-2_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8245-7
Online ISBN: 978-1-4613-0919-2
eBook Packages: Springer Book Archive